|Bid||0.5418 x 3100|
|Ask||0.5419 x 900|
|Day's Range||0.5320 - 0.5420|
|52 Week Range||0.3800 - 1.3000|
|Beta (5Y Monthly)||1.42|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 17, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Palatin Technologies, Inc. ("Palatin") (NYSE American: PTN) announced that its 2021 Annual Meeting of Stockholders that convened on June 8, 2021, has been adjourned until July 8, 2021 at 9:00 a.m. Eastern Daylight Time to solicit additional proxies for Proposal 3, approval of an amendment to our Certificate of Incorporation to effect an increase in authorized common stock from 300,000,000 shares to 400,000,000 shares. The adjourned meeting will be a completely "virtual" meeting of stockholders,
NEW YORK, NY / ACCESSWIRE / May 17, 2021 / Palatin Technologies, Inc. (NYSE:PTN) will be discussing their earnings results in their 2021 Third Quarter Earnings call to be held on May 17, 2021 at 11:00 AM Eastern Time.
Palatin (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide receptor system, today announced results for its third fiscal quarter ended March 31, 2021.